Quick Answer
WEST PHARMACEUTICAL SERVICES INC reported Total Assets of $4.27 billion for the year ending 2025.
- WEST PHARMACEUTICAL SERVICES INC showed an increase of +17.2% in Total Assets from 2024 to 2025.
- This data is from WEST PHARMACEUTICAL SERVICES INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $1.22 billion | Q3 2010: $1.30 billion | Q4 2010: $1.29 billion | Q1 2011: $1.37 billion | Q3 2011: $1.40 billion | Q1 2012: $1.46 billion | Q2 2012: $1.46 billion | Q3 2012: $1.53 billion | Q1 2013: $1.58 billion | Q2 2013: $1.61 billion | Q3 2013: $1.66 billion | Q1 2014: $1.71 billion | Q2 2014: $1.70 billion | Q3 2014: $1.67 billion | Q1 2015: $1.60 billion | Q2 2015: $1.66 billion | Q3 2015: $1.67 billion | Q1 2016: $1.67 billion | Q2 2016: $1.71 billion | Q3 2016: $1.74 billion | Q1 2017: $1.73 billion | Q2 2017: $1.84 billion | Q3 2017: $1.93 billion | Q1 2018: $1.87 billion | Q2 2018: $1.87 billion | Q3 2018: $1.95 billion | Q1 2019: $2.04 billion | Q2 2019: $2.12 billion | Q3 2019: $2.17 billion | Q1 2020: $2.25 billion | Q2 2020: $2.39 billion | Q3 2020: $2.58 billion | Q1 2021: $2.74 billion | Q2 2021: $2.93 billion | Q3 2021: $3.14 billion | Q1 2022: $3.29 billion | Q2 2022: $3.36 billion | Q3 2022: $3.32 billion | Q1 2023: $3.72 billion | Q2 2023: $3.67 billion | Q3 2023: $3.75 billion | Q1 2024: $3.60 billion | Q2 2024: $3.49 billion | Q3 2024: $3.68 billion | Q1 2025: $3.62 billion | Q2 2025: $3.95 billion | Q3 2025: $4.11 billion.
- Over the full 17 years of available data (2009 to 2025), WEST PHARMACEUTICAL SERVICES INC's Total Assets has grown by 236.0%.
- Historical annual values: Fiscal year 2025: $4.27 billion | Fiscal year 2024: $3.64 billion | Fiscal year 2023: $3.83 billion | Fiscal year 2022: $3.62 billion | Fiscal year 2021: $3.31 billion | Fiscal year 2020: $2.79 billion | Fiscal year 2019: $2.34 billion | Fiscal year 2018: $1.98 billion | Fiscal year 2017: $1.86 billion | Fiscal year 2016: $1.72 billion | Fiscal year 2015: $1.70 billion | Fiscal year 2014: $1.67 billion | Fiscal year 2013: $1.67 billion | Fiscal year 2012: $1.56 billion | Fiscal year 2011: $1.40 billion | Fiscal year 2010: $1.29 billion | Fiscal year 2009: $1.27 billion.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: